98 related articles for article (PubMed ID: 21617874)
1. Activity of aspirin analogues and vanillin in a human colorectal cancer cell line.
Deb J; Dibra H; Shan S; Rajan S; Manneh J; Kankipati CS; Perry CJ; Nicholl ID
Oncol Rep; 2011 Sep; 26(3):557-65. PubMed ID: 21617874
[TBL] [Abstract][Full Text] [Related]
2. The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer.
Kilari RS; Bashir AIJ; Devitt A; Perry CJ; Safrany ST; Nicholl ID
Curr Clin Pharmacol; 2019; 14(2):141-151. PubMed ID: 30417794
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism for the anticancer activity of aspirin and salicylates.
Bashir AIJ; Kankipati CS; Jones S; Newman RM; Safrany ST; Perry CJ; Nicholl ID
Int J Oncol; 2019 Apr; 54(4):1256-1270. PubMed ID: 30720135
[TBL] [Abstract][Full Text] [Related]
4. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
Vad NM; Yount G; Moridani MY
Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line.
Dibra HK; Brown JE; Hooley P; Nicholl ID
Oncol Rep; 2010 Jul; 24(1):37-46. PubMed ID: 20514442
[TBL] [Abstract][Full Text] [Related]
7. IPM712, a vanillin derivative as potential antitumor agents, displays better antitumor activity in colorectal cancers cell lines.
Ma W; Zhang Q; Li X; Ma Y; Liu Y; Hu S; Zhou Z; Zhang R; Du K; Syed A; Yao X; Chen P
Eur J Pharm Sci; 2020 Sep; 152():105464. PubMed ID: 32668313
[TBL] [Abstract][Full Text] [Related]
8. Glucose-aspirin: Synthesis and in vitro anti-cancer activity studies.
Jacob JN; Tazawa MJ
Bioorg Med Chem Lett; 2012 May; 22(9):3168-71. PubMed ID: 22494617
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytosolic phospholipase A2 mRNA expression: a novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells.
Yu HG; Huang JA; Yang YN; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
Regul Pept; 2003 Jul; 114(2-3):101-7. PubMed ID: 12832097
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel 20s-camptothecin analogues.
Li Q; Lv H; Zu Y; Qu Z; Yao L; Su L; Liu C; Wang L
Bioorg Med Chem Lett; 2009 Jan; 19(2):513-5. PubMed ID: 19056266
[TBL] [Abstract][Full Text] [Related]
12. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
13. Oligo(3-hydroxybutanoate) conjugates with acetylsalicylic acid and their antitumour activity.
Juzwa M; Rusin A; Zawidlak-Wegrzyńska B; Krawczyk Z; Obara I; Jedliński Z
Eur J Med Chem; 2008 Aug; 43(8):1785-90. PubMed ID: 18162262
[TBL] [Abstract][Full Text] [Related]
14. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
15. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.
Sun Y; Rigas B
Cancer Res; 2008 Oct; 68(20):8269-77. PubMed ID: 18922898
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents.
Rubner G; Bensdorf K; Wellner A; Kircher B; Bergemann S; Ott I; Gust R
J Med Chem; 2010 Oct; 53(19):6889-98. PubMed ID: 20857911
[TBL] [Abstract][Full Text] [Related]
17. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
Ding JH; Yuan LY; Huang RB; Chen GA
Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
[TBL] [Abstract][Full Text] [Related]
18. Anti-MDR and antitumoral action of acetylsalicylic acid on leukaemic cells.
Carrett-Dias M; Votto AP; Filgueira Dde M; Almeida DV; Vallochi AL; D'Oca MG; Marins LF; Trindade GS
Biosci Rep; 2011 Oct; 31(5):391-8. PubMed ID: 21361874
[TBL] [Abstract][Full Text] [Related]
19. Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB.
Gkaniatsou EI; Banti CN; Kourkoumelis N; Skoulika S; Manoli M; Tasiopoulos AJ; Hadjikakou SK
J Inorg Biochem; 2015 Sep; 150():108-19. PubMed ID: 25997576
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
Dial EJ; Doyen JR; Lichtenberger LM
Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
